GRMC is currently caring for 11 COVID patients in addition to our non-COVID census.

GRMC Statistics: The 7-day moving average for COVID hospitalizations is 12 per day. The 7-day moving average for new COVID admissions is 1-2 patients per day. For the last six weeks, the San Antonio region has seen a continuous decrease in the percentage of hospitalizations for COVID-19.

85% of patients hospitalized at GRMC for COVID-19 since June 23, 2021 are unvaccinated or not fully vaccinated. Following CDC guidelines, GRMC considers people who are two weeks out from completion of second doses of the Moderna or Pfizer vaccines or one dose of the J&J vaccine to be “fully vaccinated”.

GRMC encourages the public to continue to practice prevention measures. Get vaccinated if your family doctor says you are an appropriate candidate.

GRMC’s Regional Infusion Center: Guadalupe Regional Medical Center continues to host a regional infusion center for delivery of monoclonal antibody infusion to persons with active COVID-19 disease. The center is capable of providing up to 50 monoclonal antibody infusions per day. Texas Department of Emergency Management (TDEM) is providing staffing resources through a third-party contract to staff the healthcare providers necessary to administer infusions.

Patients who test positive for COVID-19 with mild to moderate disease and risk factors for progression to severe disease are candidates for monoclonal antibody infusions. Infusions are for treatment of active COVID-19 disease and should not be confused with the protective effect of vaccination.

Patients who are eligible for the monoclonal antibody medication:

• Patient must NOT be hospitalized or require oxygen therapy.
• Patient must NOT require an increase in oxygen rate, if using for underlying condition, due to COVID-19.
• Patient MUST be within 10 days of symptom onset.

Patients can contact the infusion center by calling (830) 481-4332. Doctors can contact the infusion center to obtain a referral form by faxing a request to (830) 401-8267.